SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is experiencing significant momentum and investor excitement as the community anticipates critical clinical data regarding pancreatic cancer to be shared at the Digestive Disease Week conference. The stock is a primary focus for many traders who are highlighting a series of upcoming clinical milestones and trial expansions as key drivers for long-term growth.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense market activity following a blowout earnings report and the announcement of a multi-billion dollar share buyback, which has sparked a battle between investors capitalizing on the companys massive growth in AI-driven NAND storage demand and those taking profits after a significant year-long rally. While some traders are expressing frustration over the volatile price action and sell-the-news dynamics, the community remains heavily focused on the company's structural pricing power and long-term supply agreements as indicators of sustained value.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp. is experiencing a massive short squeeze driven by its extremely low float and high cost-to-borrow rates, sparking intense community speculation about potential triple-digit price levels. Investors are actively debating whether this movement is a sustainable pivot toward telecommunications infrastructure or a classic high-risk pump-and-dump scenario.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending due to a combination of a significant pipeline update regarding its CUE-401 autoimmune candidate and a fresh milestone payment from its partnership with Boehringer Ingelheim. The community is actively debating the company's long-term pivot toward autoimmune therapies under new leadership, while traders weigh the impact of potential financial restructuring against the stock's recent volatility.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is experiencing intense selling pressure following a disappointing quarterly report that featured lowered forward bookings guidance and engagement concerns, leaving the community deeply divided over its long-term viability. While some investors are aggressively buying the dip, citing user growth potential and strong cash flow, critics are actively shorting the stock, citing ongoing regulatory scrutiny regarding child safety and lackluster profitability.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is seeing heavy community debate following a robust quarterly report that featured record revenue and a massive share buyback, even as some investors question the stock's valuation and the upcoming leadership transition to John Ternus. Traders are actively analyzing the company's forward guidance and the potential impact of rising memory costs on future margins.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following a significant earnings beat that surpassed top and bottom-line expectations, fueling community debate over the company's long-term monetization potential through AI data licensing. Investors and traders are actively discussing the stock's high growth trajectory and the potential for a short squeeze as they weigh these strong financials against broader market volatility.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is facing significant volatility as investors weigh the broader impact of global energy shocks, geopolitical tensions in the Middle East, and the looming transition in Federal Reserve leadership. The community is sharply divided, with traders closely monitoring the impact of persistently high oil prices and potential debt-to-GDP concerns on bond yields, while actively debating the timing of a potential rotation into duration as a hedge against inflation and economic uncertainty.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing significant downward pressure and intense community scrutiny following the announcement of an 80 million dollar common stock and pre-funded warrant offering. Investors are actively debating the necessity of this dilution, with many expressing deep frustration over the company's capital management, leadership performance, and the threat of another potential reverse split.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently seeing heightened volatility and intense community debate as the stock faces downward pressure despite significant AI-driven capital expenditure trends across the tech sector. Investors remain divided, with some pointing to competition from custom silicon and market manipulation, while others view the pullback as a buying opportunity given the company's entrenched role in the AI hardware stack.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Greenwich LifeSciences (NASDAQ:GLSI) Cut to "Sell" at Wall Street Zen

Wall Street Zen lowered shares of Greenwich LifeSciences from a "hold" rating to a "sell" rating in a research note on Saturday...

HC Wainwright Has Bearish Estimate for GLSI FY2026 Earnings

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Research analysts at HC Wainwright dropped their FY2026 EPS estimates for shares of Greenwich LifeSciences in a research report issued on...

Shares of GLSI rise premarket on Monday (Representative image: Getty Images)

Why Did GLSI Stock Rise Pre-Market Today?  

Greenwich LifeSciences Inc company unveiled new Phase 3 data suggesting its breast cancer vaccine candidate could work across a broader patient population than initially targeted

Equity

The company unveiled new Phase 3 data suggesting its breast cancer vaccine candidate could work across a broader patient population than initially targeted


Greenwich LifeSciences (GLSI) Expected to Announce Earnings on Tuesday

Greenwich LifeSciences (NASDAQ:GLSI) will be releasing earnings after the market closes on Tuesday, April 21. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-21-greenwich-lifesciences-inc-stock...

Greenwich LifeSciences (GLSI) Expected to Announce Quarterly Earnings on Tuesday

Greenwich LifeSciences (NASDAQ:GLSI) will be releasing earnings after the market closes on Tuesday, March 31. (View Earnings Report at...

<ul class="summary-bullets"><li>Greenwich noted that despite the absence of a placebo arm, GLSI-100 showed an annual recurrence rate below 1%, compared with about 4% in the KATHERINE trial of Kadcyla over a similar timeframe.</li><li>The company also stated that the Phase III trial results are trending in line with those from the Phase IIb trial.</li><li>Greenwich reported a reduction of up to 80% in breast cancer recurrences, while other approved products showed a reduction of 20% to 25%, the company said.</li></ul>Greenwich LifeSciences Inc. (GLSI) shares gained more than 13% in Tuesday’s pre-market trade after the company announced that its immunotherapy trial has shown a continued reduction in the rate of recurrence of breast cancer.Greenwich LifeSciences said its 250-patient Phase III breast cancer immunotherapy trial, FLAMINGO-01, showed an annual recurrence rate below 1%.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/GLSI">Greenwich LifeSciences</a> trended in the ‘extremely bullish’ territory with message volumes at ‘extremely high’ levels. GLSI was the top trending ticker on the platform at the time of writing.<h2 class="st-heading-2">Results Show About 70-80% Reduction In Recurrence Rate, Says Greenwich</h2>Greenwich noted that despite the absence of a placebo arm, GLSI-100 showed an annual recurrence rate below 1%, compared with about 4% in the KATHERINE trial of Kadcyla over a similar timeframe.The company also stated that the results of the Phase III trial are trending in line with those from the Phase IIb results. Greenwich reported a reduction of up to 80% in breast cancer recurrences, while other approved products showed a reduction of 20% to 25%, the company said.However, Greenwich stated that these Phase III trial results are still preliminary and that the final analysis may differ.The Phase III FLAMINGO-01 trial is designed to evaluate the safety and efficacy of GLSI-100 in HER2-positive breast cancer patients with residual disease or high-risk pathological complete response who have completed neoadjuvant and adjuvant trastuzumab-based therapy.<h2 class="st-heading-2">What Does Greenwich LifeSciences Do?</h2>Greenwich LifeSciences is a clinical-stage biopharmaceutical company based out of Stafford, Texas. It is currently focused on the development of GP2, which is an immunotherapy to prevent breast cancer recurrence in patients who have previously undergone surgery.<a href="https://stocktwits.com/symbol/GLSI">GLSI stock</a> is up 34% year-to-date and 134% over the past 12 months. The iShares Russell 2000 Growth ETF (IWO) is up 22% over the past 12 months, while the iShares Micro-Cap ETF (IWC) is up 40%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-says-fed-chair-powell-should-cut-rates-right-now/cZ3PPPaRIfw">Trump Says Fed Chair Powell Should Cut Rates Right Now</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is GLSI Stock Rising Today?

Greenwich LifeSciences said its Phase III breast cancer immunotherapy trial, involving 250 patients, showed a recurrence rate of under 1% per year.

Greenwich LifeSciences (NASDAQ:GLSI) Trading Up 11.6% - Should You Buy?

Greenwich LifeSciences (NASDAQ:GLSI) Trading Up 11.6% - Time to Buy...

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 14.7% in January

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) was the target of a significant drop in short interest in January. As of January 30th, there was short interest totaling 1,318,481 shares...

HC Wainwright Issues Positive Forecast for GLSI Earnings

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Stock analysts at HC Wainwright upped their Q3 2026 earnings per share estimates for Greenwich LifeSciences in a report released on...

Greenwich LifeSciences (NASDAQ:GLSI) Stock Price Down 6.7% - Here's What Happened

Greenwich LifeSciences (NASDAQ:GLSI) Trading Down 6.7% - Here's What Happened...

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

GLSI
Greenwich LifeSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLSI News

GLSIGreenwich LifeSciences Inc